Japan Vaccine Developers Increasingly Non-pharma Firms
This article was originally published in PharmAsia News
The few Japanese vaccine makers may have to watch for competition outside of their industry as firms in other areas attempt to develop their own. Among them are Toray Industries, Morishita Jintan and NOF, not known for their involvement in pharmaceutical development. Toray is developing a vaccine against hepatitis C, Morishita one for typhoid and NOF with some institutions for a flu vaccine. The field is fairly open because only Denka Seiken and three research institutions now produce vaccines in Japan. (Click here for more - a subscription may be required
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.